Trial reportEuropean journal of clinical pharmacology2007
Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring.
Trial report in European journal of clinical pharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 6 syntheses or guidelines pooled it, 46 citations in OpenAlex.
- Packaging interventions to increase medication adherence: systematic review and meta-analysis.Current medical research and opinion · 2015Pooled it
- Pooled it
- What are validated self-report adherence scales really measuring?: a systematic review.British journal of clinical pharmacology · 2014Pooled it
- Assessing medication adherence: options to consider.International journal of clinical pharmacy · 2014Pooled it
- Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review.Journal of general internal medicine · 2010Pooled it
- The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature.Journal of the American Medical Informatics Association : JAMIAPooled it
- Exploration of smart adherence-monitoring methods in vitamin D-deficient patients: A pilot feasibility clinical study.Clinical and translational science · 2023Trial
- Impact of Electronic Medication Reminder Caps on Patient Adherence and Blood Pressure.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2021Article
- Rationale and Methods of Evaluation for ACHO, A New Virtual Assistant to Improve Therapeutic Adherence in Rural Elderly Populations: A User-Driven Living Lab.International journal of environmental research and public health · 2021Observational
- Article
- Outcome measures for adherence data from a medication event monitoring system: A literature review.Journal of clinical pharmacy and therapeutics · 2019Review
- Evaluation of a Novel Wellness Assessment Device (Preventiometer): A Feasibility Pilot Study.Global advances in health and medicine · 2019Article
- Review
- A Comparison between The Effectiveness of Short Message Service and Reminder Cards Regarding Medication Adherence in Patients with Hypertension: A Randomized Controlled Clinical Trial.International journal of community based nursing and midwifery · 2016Article
- The Impact of Information Technology on Patient Engagement and Health Behavior Change: A Systematic Review of the Literature.JMIR medical informatics · 2016Article
- The effect of medical device dose-memory functions on patients' adherence to treatment, confidence, and disease self-management.Patient preference and adherence · 2014Review
- A new electronic monitoring device to measure medication adherence: usability of the Helping Hand™.Sensors (Basel, Switzerland) · 2010Article
- Adherence: a review of education, research, practice and policy in Switzerland.Pharmacy practice · 2009Article
- Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation.Clinical pharmacokinetics · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe goal of this study was to evaluate clinically the acceptability of the IDAS II (Intelligent Drug Administration System), a new electronic device that enables drug adherence monitoring.
methodsIDAS II was compared to another electronic monitor, the Medication Event Monitoring System (MEMS) in a randomised two-way cross-over study involving 24 hypertensive patients treated with irbesartan. Patients used each device for 2 months. The main parameter of evaluation was the patients' opinion on both devices. Rates of adherence and blood pressure were also assessed.
resultsMost patients considered both devices to be reliable reminders (IDAS II: 75%;MEMS: 84%, p = ns). Ten patients (42%) preferred the MEMS, while 11 (46%) preferred the IDAS II; three (12%) expressed no preference. Patients found the MEMS device easier to use than the IDAS device (p < 0.001) but appreciated the IDAS blister packs better than the MEMS bulk packaging (p < 0.01). Over the 4-month period, the median "taking adherence" was excellent (99.2%) and comparable with both devices. However, the regularity of drug intake timing was higher with the IDAS II (p < 0.01).
conclusionIDAS II, a new electronic device enabling drug adherence monitoring without reconditioning of the drugs appears to be a well-accepted device. Overall, practicability and acceptability of the IDAS II and the MEMS device were similar. Thus, IDAS II could be a useful tool for the management of long-term therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.